(Q34668221)

3 August 2017

title

Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial (English)

1 reference

3 August 2017

0 references

0 references

R D Elwes

1

1 reference

3 August 2017

H Crewes

2

1 reference

3 August 2017

L P Chesterman

3

1 reference

3 August 2017

B Summers

4

1 reference

3 August 2017

P Jenner

5

1 reference

3 August 2017

C D Binnie

6

1 reference

3 August 2017

J D Parkes

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 1989

1 reference

3 August 2017

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

8671

1 reference

3 August 2017

page(s)

1067-1069

1 reference

Treatment of narcolepsy with L-tyrosine

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Excessive daytime sleepiness in man: Multiple sleep latency measurement in narcoleptic and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Behavioural and biochemical effects of tryptophan, tyrosine and phenylalanine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Effects of dietary tyrosine, phenylalanine, and tryptophan on aggression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Tyrosine for the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

L-tyrosine in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

The production of amines by bacteria: The production of tyramine by Streptococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

The origin of urinary tyramine. Formation in tissues and by intestinal microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

The tyramines: Functionally significant biogenic amines or metabolic accidents?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

Role of precursor availability in control of monoamine biosynthesis in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991081-7

7 January 2021

10.1016/S0140-6736(89)91081-7

Identifiers

DOI

1 reference

3 August 2017

1 reference